Annual Total Liabilities
$7.47 M
+$4.61 M+161.26%
31 December 2023
Summary:
Biodexa Pharmaceuticals annual total liabilities is currently $7.47 million, with the most recent change of +$4.61 million (+161.26%) on 31 December 2023. During the last 3 years, it has risen by +$3.25 million (+76.88%). BDRX annual total liabilities is now -70.61% below its all-time high of $25.41 million, reached on 01 December 2015.BDRX Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Liabilities
$6.63 M
-$842.10 K-11.27%
01 June 2024
Summary:
Biodexa Pharmaceuticals quarterly total liabilities is currently $6.63 million, with the most recent change of -$842.10 thousand (-11.27%) on 01 June 2024. Over the past year, it has increased by +$3.27 million (+97.35%). BDRX quarterly total liabilities is now -73.92% below its all-time high of $25.41 million, reached on 01 December 2015.BDRX Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BDRX Total Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +161.3% | +97.3% |
| 3 y3 years | +76.9% | +5.9% |
| 5 y5 years | +67.3% | +38.3% |
BDRX Total Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +161.3% | -11.3% | +149.5% |
| 5 y | 5 years | -49.7% | +161.3% | -55.4% | +149.5% |
| alltime | all time | -70.6% | +161.3% | -73.9% | +149.5% |
Biodexa Pharmaceuticals Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| June 2024 | - | $6.63 M(-11.3%) |
| Dec 2023 | $7.47 M(+161.3%) | $7.47 M(+122.4%) |
| June 2023 | - | $3.36 M(+17.5%) |
| Dec 2022 | $2.86 M(-13.9%) | $2.86 M(+7.6%) |
| June 2022 | - | $2.66 M(-20.0%) |
| Dec 2021 | $3.32 M(-21.4%) | $3.32 M(-46.9%) |
| June 2021 | - | $6.26 M(+48.2%) |
| Dec 2020 | $4.22 M(-71.6%) | $4.22 M(-53.9%) |
| June 2020 | - | $9.17 M(-38.3%) |
| Dec 2019 | $14.86 M | $14.86 M(+210.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2019 | - | $4.79 M(+7.3%) |
| Dec 2018 | $4.47 M(-77.3%) | $4.47 M(-72.6%) |
| June 2018 | - | $16.31 M(-17.0%) |
| Dec 2017 | $19.66 M(+45.9%) | $19.66 M(+78.5%) |
| June 2017 | - | $11.02 M(-18.2%) |
| Dec 2016 | $13.47 M(-47.0%) | $13.47 M(-37.0%) |
| June 2016 | - | $21.37 M(-15.9%) |
| Dec 2015 | $25.41 M(+249.3%) | $25.41 M(+214.4%) |
| June 2015 | - | $8.08 M(+11.1%) |
| Dec 2014 | $7.27 M(-0.1%) | $7.27 M |
| Dec 2013 | $7.28 M | - |
FAQ
- What is Biodexa Pharmaceuticals annual total liabilities?
- What is the all time high annual total liabilities for Biodexa Pharmaceuticals?
- What is Biodexa Pharmaceuticals annual total liabilities year-on-year change?
- What is Biodexa Pharmaceuticals quarterly total liabilities?
- What is the all time high quarterly total liabilities for Biodexa Pharmaceuticals?
- What is Biodexa Pharmaceuticals quarterly total liabilities year-on-year change?
What is Biodexa Pharmaceuticals annual total liabilities?
The current annual total liabilities of BDRX is $7.47 M
What is the all time high annual total liabilities for Biodexa Pharmaceuticals?
Biodexa Pharmaceuticals all-time high annual total liabilities is $25.41 M
What is Biodexa Pharmaceuticals annual total liabilities year-on-year change?
Over the past year, BDRX annual total liabilities has changed by +$4.61 M (+161.26%)
What is Biodexa Pharmaceuticals quarterly total liabilities?
The current quarterly total liabilities of BDRX is $6.63 M
What is the all time high quarterly total liabilities for Biodexa Pharmaceuticals?
Biodexa Pharmaceuticals all-time high quarterly total liabilities is $25.41 M
What is Biodexa Pharmaceuticals quarterly total liabilities year-on-year change?
Over the past year, BDRX quarterly total liabilities has changed by +$3.27 M (+97.35%)